Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ABBLO PHARMA ApS
APS
Active
CVR 34080534
Gotfred Rodes Vej 8, 2920
Charlottenlund
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2011
1 employees
Watchlist
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
ABBLO PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
376
740
1.056
806
855
Staff expenses
-123
-425
-699
-626
-517
EBITDA
253
316
358
180
338
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
253
316
358
180
338
Net financials
-39
-30
-57
-73
-203
Profit before tax
214
285
301
107
135
Tax
-0
-0
-0
-0
-0
Net profit
214
285
301
107
135
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
764
882
1.162
1.499
1.366
Equity
-914
-629
-328
-221
-86
Long-term debt
1.008
934
923
889
963
Short-term debt
670
578
567
831
489
Total debt
1.679
1.511
1.490
1.720
1.452
Financial ratios
5-year trend
EBITDA-margin
39.5%
This company
15.8%
Market median
+150% vs market
2020
2024
Soliditetsgrad
-6.3%
This company
38.2%
Market median
-116% vs market
2020
2024
Egenkapitalforrentning
13521500.0%
This company
18.4%
Market median
+73486313% vs market
2020
2024
Nettoresultatgrad
15.8%
This company
8.1%
Market median
+95% vs market
2020
2024
Aktivomsætning
0.63×
This company
1.12×
Market median
-44% vs market
2020
2024
Gæld/egenkapital
16.92×
This company
0.62×
Market median
-2629% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on ABBLO PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
